2019
|
Invention
|
Humanized and de-immunized antibodies. The invention relates to humanized and de-immunized antibo... |
2018
|
Invention
|
Inhibitors of glutaminyl cyclase. The invention relates to a compound of formula (I): Formula (I)... |
|
Invention
|
Novel inhibitors. The invention relates to a compound of formula (I): A-B-D-E (I) or a pharmaceut... |
2016
|
Invention
|
Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseases.
A method... |
|
Invention
|
Anti-pyroglutamated amyloid beta humanized antibodies. The invention relates to humanized antibod... |
2015
|
Invention
|
Novel method for the detection of pglu-abeta peptides.
The invention relates to a highly sensiti... |
|
Invention
|
Novel method for the detection of pglu-abeta peptides. The invention relates to a highly sensitiv... |
|
Invention
|
Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe).
Monoc... |
|
Invention
|
Transgenic mouse expressing human isoglutaminyl cyclotransferase.
A transgenic non-human animal ... |
2014
|
Invention
|
Radiolabelled glutaminyl cyclase (qc) inhibitors and uses of same. Radiolabeled glutaminylcyclase... |
|
Invention
|
Novel inhibitors. The invention relates to a compound of formula (I) or a pharmaceutically accept... |
2013
|
Invention
|
Mouse models carrying a knock-out mutation of the qpctl-gene. A knock-out non-human animal, in pa... |
|
Invention
|
Crystal structure of glutaminyl cyclase. Novel crystal structures of human and murine glutaminyl ... |
2012
|
Invention
|
In vivo screening models for treatment of qc-related disorders.
A double transgenic non-human an... |
|
Invention
|
In vivo screening models for treatment of qc-related disorders. The present invention provides a ... |
|
Invention
|
Radiolabelled glutaminyl cyclase inhibitors. The invention relates to the use of radiolabelled gl... |
|
Invention
|
Radiolabeled glutaminyl cyclase (qc) inhibitors and uses of same. Radiolabeled glutaminylcyclase ... |
|
Invention
|
Diagnostic antibody assay. The present invention pertains to novel diagnostic assays for the diag... |
|
Invention
|
Benz imidazole derivatives as inhibitors of glutaminyl cyclase. The invention relates to novel he... |
|
Invention
|
Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase i... |
2011
|
Invention
|
Screening method for enzyme inhibitors. Novel glutaminyl-peptide cyclotransferase-like proteins (... |
|
Invention
|
Crystal structure of isoglutaminyl cyclase. The invention relates to novel crystal structures of ... |
|
Invention
|
Crystal structure of isoglutaminyl cyclase. A crystal comprising human isoglutaminyl cyclase havi... |
|
Invention
|
In vivo screening models for treatment of isoqc-related disorders.
A transgenic non-human animal... |
|
Invention
|
In vivo screening models for treatment of isoqc-related disorders. The present invention provides... |
|
Invention
|
Crystal structure of glutaminyl cyclase. The invention relates to novel crystal structures of hum... |
|
Invention
|
Crystal structure of glutaminyl cyclase. A novel crystal structures of human and murine glutaminy... |
|
Invention
|
Benzimidazole derivatives as inhibitors of glutaminyl cyclase. The invention relates to novel het... |
|
Invention
|
Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5). The invention relates to novel he... |
|
Invention
|
Inhibitors of glutaminyl cyclase. The invention relates to novel heterocyclic derivatives as inhi... |
|
Invention
|
Novel diagnostic method.
A method of monitoring treatment of an inflammatory disease or an infla... |
|
Invention
|
Methods of diagnosing inflammatory diseases by determining pyroglutamate-modified mcp-1 and scree... |
2010
|
Invention
|
Cleavage of β-amyloid precursor protein. The present invention concerns methods and means for the... |
|
Invention
|
Cleavage of b-amyloid precursor protein.
Methods and means for the identification of meprin-α an... |
|
Invention
|
Novel diagnostic method.
Provided herein are methods, compositions, and kits related to the dete... |
|
Invention
|
Novel diagnostic method for the diagnosis of alzheimer's disease or mild cognitive impairment. Th... |
|
Invention
|
Novel assay.
A novel method for detection of Aβ peptides, in particular in plasma, and to the us... |
|
Invention
|
Novel assay for the detection of amyloid beta peptides. The present invention pertains to a novel... |
|
Invention
|
Heterocylcic derivatives as inhibitors of glutaminyl cyclase. The invention relates to novel pyrr... |
|
Invention
|
Mouse models carrying a knock-out mutation of the qpctl-gene. The present invention provide... |
|
Invention
|
Mouse models carrying a knock-out mutation of the qpctl-gene. The present invention provides a kn... |
|
Invention
|
Mouse models carrying a knock-out mutation of the qpctl-gene.
A knock-out non-human animal, in p... |
|
Invention
|
Enzyme inhibitors.
There is disclosed herein methods for using compounds of formula (I),
There... |
2009
|
Invention
|
Combinations useful for the treatment of neuronal disorders.
The present invention provides a me... |
2008
|
Invention
|
Novel compounds.
The invention provides compounds of general formula (I)
The invention provide... |